3-(4-(((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)amino)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
Lenalidomide Lactosamine Adduct is a fully characterized chemical compound used as a reference standard of API Lenalidomide. The standard offered is compliant with regulatory guidelines. Lenalidomide Lactosamine Adduct is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Lenalidomide Benzo[d]isothiazol-3(2H)-one 1,1-dioxide Impurity
![Picture of Lenalidomide Benzo[d]isothiazol-3(2H)-one 1,1-dioxide Impurity](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-L06003.jpg?size=256 "Show details for Lenalidomide Benzo[d]isothiazol-3(2H)-one 1,1-dioxide Impurity")
M.F. C₂₀H₁₅N₃O₆S
M.W. 425.42
CAT# AR-L06003
CAS# NA
2-(Bromomethyl)-3-nitrobenzoic Acid Methyl Ester
M.F. C₉H₈BrNO₄
M.W. 274.07
CAT# AR-L01321
CAS# 98475-07-1
2-(4-Amino-1-oxoisoindolin-2-yl) pentanedioic Acid (Lenalidomide Open Ring Diacid)
M.F. C₁₃H₁₄N₂O₅
M.W. 278.26
CAT# AR-L01319
CAS# 295357-66-3
(S)-3-Amino-piperidine-2,6-dione Hydrochloride
M.F. C₅H₈N₂O₂ ; HCl
M.W. 128.13 ; 36.46
CAT# AR-L05991
CAS# 25181-50-4
